Henan Lingrui Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Henan Lingrui Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Hainan Haiyao Company Limited
sales of 1.54 billion Chinese Renmimbi [US$224.06 million]
of which 68%
Porton Fine Chemicals Ltd
(1.33 billion Chinese Renmimbi [US$192.54 million]
of which 81%
was Pharmaceutical R&D Production), and
Shandong Jincheng Pharmaceutical Group Co Ltd
(1.42 billion Chinese Renmimbi [US$206.15 million]
of which 85%
was Medicine Manufacturing).
Henan Lingrui Pharmaceutical Co., Ltd. reported sales of 1.44 billion Chinese Renmimbi (US$208.85 million)
December of 2016.
increase of 34.5%
versus 2015, when the company's sales were 1.07 billion Chinese Renmimbi.
Sales at Henan Lingrui Pharmaceutical Co., Ltd. have increased during each of the previous five years
(and since 2011, sales have increased a total of 221%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
126.2% in 2016, from
13.55 million Chinese Renmimbi to 30.64 million Chinese Renmimbi.